Madrigal Pharmaceuticals Reports Q2 2024 Financial Results and Provides Updates
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced its financial results for the second quarter ending June 30, 2024. The company reported net sales of $14.6 million, driven by …
Madrigal Pharmaceuticals Reports Q2 2024 Financial Results and Provides Updates Read More